Nephron Pharmaceuticals is based in West Columbia. It has raised $350M in total funding.
Nephron Pharmaceuticals funding overview
Nephron Pharmaceuticals is based in West Columbia. Nephron Pharmaceuticals has raised $350M in total disclosed funding. That places its disclosed total in the $250M–$1B range. The round record for Nephron Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include BlackRock Capital Investment Advisors, LLC, PNC Bank, National Association. 2 distinct backers are named across the disclosed rounds.
Nephron Pharmaceuticals at a glance
Total raised
$350M
Latest round date
September 2023
Headquarters
West Columbia
Notable investors
BlackRock Capital Investment Advisors, LLC, PNC Bank, National Association
Frequently asked about Nephron Pharmaceuticals funding
How much has Nephron Pharmaceuticals raised?
Nephron Pharmaceuticals has raised $350M in total disclosed funding across the rounds on record.
Who has invested in Nephron Pharmaceuticals?
BlackRock Capital Investment Advisors, LLC, PNC Bank, National Association are named among the investors backing Nephron Pharmaceuticals.
What was the latest Nephron Pharmaceuticals funding round?
No round stage has been disclosed for Nephron Pharmaceuticals.
Where is Nephron Pharmaceuticals based?
Nephron Pharmaceuticals is based in West Columbia.
When did Nephron Pharmaceuticals last raise?
The last disclosed Nephron Pharmaceuticals round closed in September 2023.
Every Nephron Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in West Columbia at a similar stage.
